Increased activity of histone deacetylases in childhood acute lymphoblastic leukaemia and acute myeloid leukaemia: support for histone deacetylase inhibitors as antileukaemic agents

Abstract excerpt

The importance of epigenetic mechanisms, such as DNA methylation and histone acetylation, in human cancer development is becoming increasingly clear (Bolden et al, 2006; Chen et al, 2010). Genomic analyses of patient samples have revealed that genes encoding chromatin modifier proteins are among the most frequently mutated genes in cancer (Morin et al, 2011; Mullighan et al, 2011; Pasqualucci et al, 2011). In...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Histone Deacetylase Inhibitors Research
• Share to Protein Degradation and Inhibitors